Lilly Joins the Push for Non-Opioid Painkillers

2020-12-10T19:32:22+00:00

In Pharma Lilly joins the push for non-opioid painkillers 03-Jun-2019 By Maggie Lynch Eli Lilly acquires exclusive worldwide rights for non-opioid treatment for chronic pain from Centrexion through a licensing agreement. HTTPS://WWW.IN-PHARMATECHNOLOGIST.COM/ARTICLE/2019/06/03/ELI-LILLY-LICENSES-NON-OPIOID-TREATMENT-FOR-47.5M 

Lilly Joins the Push for Non-Opioid Painkillers2020-12-10T19:32:22+00:00
Go to Top